4//SEC Filing
FEBBO WILLIAM J 4
Accession 0001628280-24-027755
CIK 0001448431other
Filed
Jun 11, 8:00 PM ET
Accepted
Jun 12, 11:41 AM ET
Size
9.1 KB
Accession
0001628280-24-027755
Insider Transaction Report
Form 4
OptimizeRx CorpOPRX
FEBBO WILLIAM J
DirectorCEO
Transactions
- Exercise/Conversion
Common Stock
2024-04-18+28,895→ 582,035 total - Tax Payment
Common Stock
2024-04-18$9.35/sh−782$7,312→ 581,253 total - Exercise/Conversion
Restricted Stock Units
2024-04-18−28,895→ 57,790 total→ Common (28,895 underlying)
Footnotes (4)
- [F1]Restricted stock units convert into common stock on a one-for-one basis.
- [F2]The Reporting Person's prior holdings were previously inadvertently overstated by four shares.
- [F3]These shares were withheld by the Issuer to satisfy the Reporting Person's tax withholding obligations. Such withholding is treated as a disposition of securities under Section 16 of the Securities Exchange Act of 1934, as amended.
- [F4]On April 18, 2023, the Reporting Person was granted 86,685 restricted stock units, vesting in three equal annual installments beginning on the first anniversary of the grant date.
Documents
Issuer
OptimizeRx Corp
CIK 0001448431
Entity typeother
Related Parties
1- filerCIK 0001413987
Filing Metadata
- Form type
- 4
- Filed
- Jun 11, 8:00 PM ET
- Accepted
- Jun 12, 11:41 AM ET
- Size
- 9.1 KB